Supply Chain Analytics Market is Projected to Rise at a CAGR of 16.4% During The Forecast Period

The Report Supply Chain Analytics Market Analysis Report By Enterprise Size, By Service, By Deployment, By Solution, By End-use (High Technology Products, Manufacturing, Healthcare), And Segment Forecasts, 2018 - 2025

The global supply chain analytics market size is projected to reach USD 9.88 billion by 2025, according to a new study by Grand View Research, Inc., rising at a CAGR of 16.2% during the forecast period. Growing need to manage a large amount of business data and use derived insights is triggering the demand for supply chain analytics. Increasing awareness among enterprises regarding benefits offered by supply chain analytics is instrumental in accelerating the demand for analytic solutions in order to improve perceptibility levels across the entire supply chain enablers.

Supply chain analytics solutions can help enterprises achieve growth, enhance profitability, and increase market shares by utilizing derived insights for making strategic decisions. These solutions can also offer a holistic view of supply chain and help in enhancing sustainability, reducing inventory cost, and accelerating time-to-market for products in the long run.

Factors such as ineffective supplier networks, shortening product life cycles, elevated warehousing costs, redundant forecasts, low supply chain visibility, and fluctuating customer demands are also facilitating supply chain optimization, thereby driving the market.

Improved outcomes and cost-effectiveness of supply chain management resulting from the adoption of supply chain analytics is anticipated to encourage the adoption of these solutions in various end-use applications, such as retail & consumer goods, healthcare, and manufacturing. The ability of supply chain analytics to enable effective and efficient management of end-to-end supply processes is estimated to stimulate the growth of the market over the forecast period.

Access Research Report of Supply Chain Analytics Market@ www.grandviewresearch.com/industry-analysis/the-global-supply-chain-analytics-market

Further key findings from the study suggest:

• Sales & operations analytics was the leading solution segment in 2017 because of surging use of machine learning in supply chain analytics solutions to dissect and aggregate data and produce predictive, descriptive, and prescriptive insights. The segment is estimated to post a CAGR of 13.9% over the forecast period
• The professional segment is likely to dominate the supply chain analytics services market over the forecast period. Growing automation of professional services due to rising adoption of big data and analytics coupled with surging demand for improved mobility among service consultants is poised to escalate the growth of the segment
• Cloud deployment is expected to remain the most preferred method of deployment of supply chain analytics solutions. The cloud segment is projected to expand at a CAGR of 17.6% over the forecast period.
• The high technology product segment is anticipated to exhibit the highest CAGR of 19.4% over the forecast period
• The manufacturing segment is estimated to dominate the market throughout the forecast horizon as enterprises are trying to reduce the cost of supply chain as part of their efforts to reduce the overall product cost
• Accenture PLC; Aera Technology; Birst, Inc.; Capgemini SA; Genpact Limited; IBM; JDA Software Group, Inc.; Kinaxis; Lockheed Martin Corporation; Maersk Group; and Manhattan Associates, Inc. are some of the key market incumbents of the supply chain analytics market

Grand View Research has segmented the global supply chain analytics market based on solution, service, deployment, enterprise size, end use, and regions:

Supply Chain Analytics Solution Outlook (Revenue, USD Million, 2014 - 2025)

• Logistics Analytics
• Manufacturing Analytics
• Planning & Procurement
• Sales & Operations Analytics
• Visualization & Reporting

Supply Chain Analytics Service Outlook (Revenue, USD Million, 2014 - 2025)

• Professional
• Support & Maintenance

Supply Chain Analytics Deployment Outlook (Revenue, USD Million, 2014 - 2025)

• Cloud
• On-premise

Supply Chain Analytics Enterprise Size Outlook (Revenue, USD Million, 2014 - 2025)

• Large Enterprise
• Small & Medium Enterprises

Supply Chain Analytics End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Retail & Consumer Goods
• Healthcare
• Manufacturing
• Transportation
• Aerospace & Defense
• High Technology Products
• Others

Supply Chain Analytics Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Photoelectric Sensors Market Industry Size, Driving Demands by 2025

The global photoelectric sensors market size is expected to reach USD 2.09 billion by 2025, according to a new report by Grand View Research, Inc., registering a 6.1% CAGR during the forecast period. These sensors are widely used in packaging and manufacturing industries as they offer numerous advantages such as cost effectiveness, long sensing distances, fast response time, and high resolution. These high-efficiency products are expected to witness an increase demand also owing to benefits such as low maintenance, long operating life, and low power consumption.

Rising penetration of Industrial Internet of Things (IIoT) is further expected to enhance market growth. This growth is attributed to numerous benefits, including maximizing asset utilization, improving productivity, and enhancing work safety. These devices help in connecting machines and devices to enhance efficiency, productivity, and operation of industrial facilities.

The photoelectric sensors market is anticipated to witness a considerable demand over the forecast period, which stems from industries such as healthcare, oil and gas, and military and aerospace across developed and developing countries.

Increasing government regulations pertaining to fuel emissions, along with increasing use of photoelectric sensors in automotive applications such as failure diagnostics, throttle control, contactless positioning sensing, and precision position measurement for better control, are key factors spurring market growth.

The emergence of smart photoelectric sensors is expected to drive market growth over the forecast period. This may be ascribed to several benefits such as reduced down time, lower cost, adaptability for self-calibration and compensation, fewer interconnections between multiple sensors and control systems, lower weight, and higher reliability.

Access Research Report of Photoelectric Sensors Market@ www.grandviewresearch.com/industry-analysis/photoelectric-sensors-market

Further key findings from the report suggest:

• The photoelectric sensors market was valued at USD 1.24  billion in 2016 and is projected to expand at a CAGR exceeding 6.0% over the forecast period. This is largely attributed to rising penetration of IIoT in industrial facilities
• By technology, the retro-reflective segment captured a major market share in 2016. The segment is also expected to grow at the highest rate over the forecast period owing to its capability to offer sturdy construction, low maintenance, and efficient detection of shiny and transparent objects
• The packaging industry as an end-use segment is expected to grow at the highest rate over the forecast period as these products are broadly adopted to detect transparent bottles, control conveyor positioning, and monitor product presence
• The Asia Pacific region is projected to witness substantial growth, exhibiting a CAGR exceeding 6.0% over the forecast period. This is owing to rising industrial automation and increasing government regulations in the developing economies of China, India, and Japan
• Key players such as Panasonic Corporation; Keyence Corporation; Rockwell Automation Inc.; Autonics Corporation; and Schneider Electric SE dominated the market in 2016, with a focus on increasing market presence through mergers and acquisitions.

Grand View Research has segmented the global photoelectric sensors market based on technology, end use, and region:

Photoelectric Sensors Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Diffused
• Retro-Reflective
• Thru-Beam

Photoelectric Sensors End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Automotive
• Military & Aerospace
• Electronics & Semiconductor
• Packaging
• Others

Photoelectric Sensors Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
  • Mexico
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Microfluidics Market to Hold a High Potential for Growth by 2027| Top Industry Leaders F. Hoffmann-La Roche Ltd; Fluidigm Corporation

The global microfluidics market size is expected to reach USD 31.6 billion by 2027, according to a new report by Grand View Research, Inc., registering an 11.3% CAGR over the forecast period. Demand for microfluidic-based devices is expected to surge owing to introduction of novel technologies such as digital microfluidics. These techniques allow on-chip biochemical analysis, thereby driving adoption.

Rise in the adoption of microfluidics for point-of-care diagnostics is expected to have a significant impact on market growth. Industry players such as Abbott, Roche, and Danaher have already incorporated this technology in their existing diagnostic devices and are exploring the scope of digital microfluidics. For instance, Philips’ Minicare I-20 handheld device provides accurate and rapid results for the diagnosis of heart attacks.

Large investments targeted toward the development of microfluidics and promoting their adoption are expected to create opportunities for the expansion for automated as well as miniature devices. For instance, according to an article published in 2018, there have been large-scale investments in “sample-to-answer” microfluidic automated testing in recent years.

Microfluidics has not only been proven beneficial in biological bench-work but also several medical and pharmaceutical applications, including diagnosis of infectious diseases and treatment of cancer. The technology aids in the fabrication of functional living tissues and artificial organs. Companies such as Abbott, Roche, Cepheid, and Becton, Dickinson and Company (BD) are integrating such technologies with in-vitro diagnostics (IVD). Samsung LABGEOPT10 and Abbott i-STAT are examples of single-step blood glucose testing assays that can work on a small sample volume (a single blood drop).

Access Research Report of Microfluidics Market@https://www.grandviewresearch.com/industry-analysis/microfluidics-market

Further key findings from the study suggest:

• The medical/healthcare segment dominated the market by technology owing to rise in demand for new molecular diagnostic tests with enhanced sensitivities, shorter turnaround time, and increased accuracy at minimal costs
• PCR & RT-PCR were the largest revenue-generating medical technology in 2019 and the segment is expected to retain its lead throughout the forecast period. Digital PCR in combination with a microfluidic device allows a large amount of PCR reaction mix to be distributed into nanoliter-sized volumes automatically
• The organs-on-chips application segment is expected to register the fastest CAGR throughout the forecast period. The method can potentially reduce the failure rate in drug development pipelines, thereby reducing the time and money associated with drug development
• By material, polydimethylsiloxane (PDMS) accounted for the largest revenue share in 2019. The material is used to fabricate microfluidic-based devices because of its nontoxicity, robustness, optical transparency, permeability, biocompatibility, elastomeric features, and low cost.
• North America dominated the global microfluidics market in 2019 and is expected to retain its dominance over the analysis period. Local presence of leading players, availability of funds and research capital, and launch of novel sample volume screening technologies drives the North America market
• Asia Pacific is expected to witness the fastest growth owing to rise in aging population, demand for point-of-care diagnostic tests, and presence of academic institutions such as the Institute of Microchemical Technology (IMT), Japan, that are focused on microfluidic-based research
• Illumina, Inc.; PerkinElmer, Inc.; Agilent Technologies, Inc.; Danaher Corporation; Bio-Rad Laboratories, Inc.; Life Technologies Corporation; Abbott Laboratories; F. Hoffmann-La Roche Ltd; and Fluidigm Corporation are some of the key players operating in the global market

Grand View Research has segmented the global microfluidics market based on technology, application, material, and region:

Microfluidics Technology Outlook (Revenue, USD Million, 2016 - 2027)

• Medical/Healthcare
  • PCR & RT-PCR
  • Gel Electrophoresis
  • Microarrays
  • ELISA
  • Others
• Non-Medical

Microfluidics Application Outlook (Revenue, USD Million, 2016 - 2027)

• Lab-on-a-chip
  • Medical
  • Non-Medical
• Organs-on-chips
  • Medical
  • Non-Medical
• Continuous flow microfluidics
  • Medical
  • Non-Medical
• Optofluidics and microfluidics
  • Medical
  • Non-Medical
• Acoustofluidics and microfluidics
  • Medical
  • Non-Medical
• Electrophoresis and microfluidics
  • Medical
  • Non-Medical

Microfluidics Material Outlook (Revenue, USD Million, 2016 - 2027)

• Silicon
• Glass
• Polymer
• PDMS
• Others

Microfluidics Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • India
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare Payer Services Market Poised to Expand at a Robust Pace of $69.2 Billion Over 2024

The global healthcare payer services market is anticipated to reach USD 69.2 billion by 2024, according to a new report by Grand View Research. The key factors driving the market include the increasing demand for streamlined business processes and better customer services through the adoption of cost effective strategies. 

The growing usage of advanced technologies to deliver economical business process services, rising adoption of digital technology, increasing focus on consumerism, and the presence of stringent healthcare regulatory policies are certain crucial factors boosting the healthcare payer services market in the coming years. Some of the key participants, such as Accenture, Cognizant, EXL, HP Development Company, L.P., Concentrix Corporation, and others, are primarily focusing on incorporating mobility technology with health plans to engage enrolled members. 

Moreover, the growing private healthcare insurance exchanges, increasing IT investments, and with the Affordable Care Act (ACA) in effect, the market is set to grow. The increasing demand to curb the overall administrative costs of member management services, increasing demand for cost effective solutions for the healthcare payer services, and the growing number of healthcare fraud cases are few determinants that are expected to propel the market growth over the forecast period. 

Some established players including United Healthcare, Inc., Anthem, Inc., Aetna, Inc., Accenture, Cognizant, Dell, HP Development Company, L.P., and Xerox Corporation are expanding their footprint through the implementation of various technologies such as digital technology and contract models. The technological advancements in the overall healthcare payer services system are anticipated to positively reinforce the market growth.  

Access Research Report of Healthcare Payer Services Market @ www.grandviewresearch.com/industry-analysis/healthcare-payer-services-market

Further Key Findings from the Study Suggest:

• In 2015, the BPO segment accounted for the maximum revenue share of 51.7%. The growing number of people enrolling for the insurance program, increasing pressure to bend the healthcare cost curve, and the rising implementation of ICD-10 codes are driving this segment’s growth. However, the KPO segment is expected to emerge as the fastest growing with a CAGR of 17.9%. Increasing demand for accurate claim resolution and the reduction of fraud incidences are some of the factors that are expected to drive the market over the forecast period.
• In 2015, North America was a clear leader with a revenue share of 77.31%. The growing insurance enrollment, lack of low-cost skilled professionals, and the increasing demand for an integrated healthcare system are accountable for the large market share captured by this segment.
• Asia Pacific is expected to emerge as the fastest growing region with a CAGR of 10.8% during the forecast period. The Southeast Asian region is one of the major outsourcing destinations in the world. The region includes Malaysia, Singapore, Vietnam, Philippines, India, China, and many more, which are predominately involved in carrying out outsourcing activities. The presence of skilled workforce to provide high-end process services, such as software development and application development management, is one of the prominent factors driving the Asia Pacific healthcare payer services market in the coming years.
• The healthcare payer services market is presently dominated by few key participants, such as United Healthcare, Inc., Anthem, Inc., Aetna, Inc., Cigna, Humana, Inc., Accenture, Xerox Corporation, Genpact, IBM Corporation, and Cognizant. The healthcare payer services players initiate merger & acquisition and corporate development strategies primarily to further expand their reach in various other verticals. For instance, Wipro Limited had acquired HealthPlan Services for approximately USD 460 million to diversify its health insurance product portfolio. 

Grand View Research has segmented the healthcare payer services market by outsourcing services, application, end use, and region: 

Healthcare Payer Services Market Outsourcing Services Outlook (Market revenue in USD Billion, 2013 - 2024)

• BPO
• KPO
• ITO

Healthcare Payer Services Market Application Outlook (Market Revenue in USD Billion, 2013 - 2024)

• Claims Management Services
• Integrated Front Office Service and Back Office Operations
• Member Management Services
• Provider Management Services
• Billing and Accounts Management Services
• Analytics and Fraud Management Services
• HR Services

Healthcare Payer Services Market End-use Outlook (Market Revenue in USD Billion, 2013 - 2024)

• Private Payer
• Public Payer

Healthcare Payer Services Market Regional Outlook (Market Revenue in USD Billion, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Demand for Transcatheter Heart Valve Market to Incur Considerable Upsurge During 2013 – 2024

The global transcatheter heart valve market is anticipated to reach a value of USD 8.62 billion by 2024, according to a new report by Grand View Research, Inc. The market is currently under-penetrated as these products are approved only for geriatric patients who cannot undergo normal valve surgeries. Growth drivers such as increasing prevalence of chronic cardiovascular diseases, increasing economic development, improvement in reimbursement scenario, and faster adoption of new technologies are expected to significantly improve the usage rates over the forecast period.

The transcatheter heart valve market is evolving rapidly due to the continuous investments in R&D by the key market players such as Edwards Life Sciences, Medtronic, St. Jude, and Boston Scientific. The technologically advanced products such as the SAPIEN 3 transcatheter heart valve and the TRINITY Valve are designed to reduce the surgical complications and improve patient compliance. For instance, the TRINITY TAVI system enables easy retrieval and repositioning of the device, without compromising on patient safety and treatment outcomes.

Furthermore, the market is expected to experience strong tailwinds on account of growing investor interest, lucrative product pipeline, faster regulatory approvals, and high competition to acquire potential start-ups. For example, some of the notable investments in the market include the USD 37 million funding of Venus MedTech by Goldman Sachs. In line with the market trends, the other market participants such as Boston Scientific, Edward Life Sciences, and Medtronic have also increased their investments to develop new products for management of mitral valve regurgitation and tricuspid valve replacements.

Access Research Report of Transcatheter Heart Valve Market @ www.grandviewresearch.com/industry-analysis/transcatheter-valve-market

Further Key Findings from the Study Suggest:

• Aortic stenosis is the most prevalent valve disease, and if untreated it can lead to death. In 2015, transcatheter aortic valve segment accounted for the maximum revenue of over USD 1.6 billion and is expected to retain its dominant share over the forecast period.
• However, the transcatheter mitral valve segment is expected to emerge as the fastest growing with a CAGR of 23% over the forecast period. Increasing number of elderly patients with mitral regurgitation and growing demand for technologically advanced transcatheter valve devices are expected to drive the usage of transcatheter mitral valves over the forecast period.
• In 2015, the self-expanded transcatheter accounted for the largest market share of 65%. These catheters are most commonly used and, currently, most of the products that are available in the market are based on this technology. However, balloon expanded transcatheters are expected to have the fastest CAGR of 16.8% over the forecast period.
• North America held the maximum share of nearly49% in 2015. A combination of different factors such as the presence of large target population, high disposable income, strong reimbursement framework, contribute toward the high revenue generated in this region.
• Asia Pacific is anticipated to register the fastest CAGR of 17.8% over the forecast period. Increasing disease burden, improvement in clinical trial regulations, growing preference for advanced medical technologies, increase in medical tourism, and special incentives for investments in healthcare sector are expected to strongly favor the growth in this region.
• Some key market players Boston Scientific Corporation, Bracco Group, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences, JenaValve, St. Jude Medical, Symetis. ValveXchange, Edwards Lifesciences, and Medtronic are the early movers in this market have captured significant market share in the North America, Europe, and the Asia Pacific region.

Grand View Research has segmented the transcatheter heart valve market by application, technology and region:

Transcatheter Heart Valve Market Application Outlook (Market revenue in USD Million, 2013 - 2024)

• Transcatheter aortic valve
• Transcatheter pulmonary valve
• Transcatheter mitral valve

Transcatheter Heart Valve Market Technology Outlook (Market revenue in USD Million, 2013 - 2024)

• Balloon expanded transcatheter valve
• Self-expanded transcatheter valve

Transcatheter Heart Valve Market Regional Outlook, (Market Revenue in USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Animation Market to Witness a Pronounce Growth During the Forecast Period| Key participants Nucleus Medical Media; Radius Digital Science

The global medical animation market is expected to reach a value of USD 514.0 million by 2024, according to a new report by Grand View Research. Key factors driving the market growth include the higher adoption of medical animation marketing by medical devices manufacturers and pharmaceutical products. It helps in explaining product features and communicating associated information with end users. 

The information represented by animation is more appealing and easy to transmit. These aforementioned benefits are expected to boost the usage rate in near future. In addition, the paradigm shift, in healthcare information technology, such as digitalization, is anticipated to contribute towards the market growth in the next few years. The medical animation market has gained momentum after the introduction of cloud-based platforms and 3D printing technology in healthcare. 

Furthermore, the introduction of technologically advanced software for image analysis, such as Medical Image Processing, Analysis, and Visualization can be attributed to the market growth. This application enables researcher from remote sites share valuable information and analyze the research data to detect, monitor, and treat medical disorders.  Medical animation is a versatile tool for communicating complex scientific procedures in an interactive manner and used in a variety of business aspects such as marketing, web presentations, social media, tradeshows and advertising. Increasing adoption of this technology is expected to serve as a potential growth driver in the future. 

The increasing investment by private and public sector, growing geriatric population coupled with increasing demand for computer-aided diagnostics, and incidence of chronic diseases are major factors fueling the increasing usage rates of this technology. In addition, this technology found application in various sectors, for instance; it helps healthcare professionals explain human body metabolism to patients, which helps in reducing patient’s anxiety level and educates them about various disease condition.  

Access Research Report of Medical Animation Market @ www.grandviewresearch.com/industry-analysis/medical-animation-market

Further Key Findings from the Study Suggest:

• Flash animation is expected to be one of the most lucrative segment in near future due to increasing demand for patient engagement by healthcare professionals. On the other hand, 3D animation found application in clinical research studies, improving patient education, and simplifying complex procedures in bioscience studies by representing them into an animated form
• Growing demand for technologically advanced medical animation solutions is expected to contribute towards the growth of 3D animation during the forecast period
• In 2015, the drug mechanism of action segment accounted for the largest revenue share. The use of animation for explaining drug interactions and metabolic studies in new drug development are key contributing factors for this segment growth. This technology is used in animating preproduction, full production and post production process of drug molecules
• However, the patient education segment is expected to emerge as the fastest growing segment as awareness levels amongst patients, introduction of user-friendly apps and concerns related to health information are increasing. For instance, introduction of 3D medical application such as complete anatomy in November 2015 by 3D4 medical used for anatomical studies
• Currently, oncology segment dominates the market and is expected to be the fastest growing therapeutic area using this technology. Increasing incidence of cancer worldwide is a key contributing factor for growing demand of medical animation studies to explain disease mechanisms to patients
• For instance, XVIVO, showcased animation software at the American Society of Clinical Oncology (ASCO) and also helped in the depiction of mechanism of action of Bavituximab, an investigative drug, believed to strengthen the immunity system in cancerous environment
• Other end users of this market are life science companies, medical device manufactures, government authorities, forensic department, medico-legal firms, and insurance provider companies. This segment is expected to grow at fastest CAGR due to wide usage of 3D bioprinting and biosimulation studies in these fields
• For example, in forensic studies, a medical animation is used to elaborate crime scene and medico-legal firms use 3D animation to explain pain management procedures, surgical techniques, and presenting anatomical studies. There are various surgical and clinical audiovisual animation studies available online
• Asia Pacific is expected to be the fastest growing region during the forecast period. The growing geriatric population, increase in the chronic diseases, and ongoing development in healthcare sector is the factors anticipated to provide future growth platform for this industry in the next 7 years
• In addition, rising outsourcing activities in this region due to availability and low cost of labor are anticipated to propel segment growth over the forecast period. For example, in India, the cost of medical animation services is 20% to 25% lower than the U.S. and Europe
• The medical animation market is experiencing high competition as there are many small and big organization that offer these services. Introduction of low-cost software solutions for medical simulation is expected to boost the competition and is also expected to benefit several end users over the forecast period
• Companies are involved in adopting sustainable strategies to gain competitive edges such as new product launch, product up gradation and collaborative agreements. For example, In April 2016, Fusion medical animation launched biotech brand services aimed at designing and developing innovative visuals for better understanding of complex products The aforementioned factors keeps the market rivalry at higher level 

Grand View Research has segmented the medical animation market by type, application, therapeutic area, end-use and region: 

Medical Animation Market Type Outlook (Market revenue in USD Million, 2013 - 2024)

• 3D Animation
• 2D Animation
• 4D Animation
• Flash Animation

Medical Animation Market Application Outlook (Market Revenue in USD Million, 2013 - 2024)

• Drug MoA
• Patient Education
• Surgical Training & Planning
• Cellular & Molecular Studies
• Others

Medical Animation Stationary Therapeutic Area Outlook (Market Revenue in USD Million, 2013 - 2024)

• Oncology
• Cardiology
• Plastic Surgery
• Dental
• Others

Medical animation Market End-use Outlook (Market Revenue in USD Million, 2013 - 2024)

• Hospitals
• Life sciences
• Academic institute
• Medical device manufactures
• Others

Medical Animation Market Regional Outlook (Market Revenue in USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Orthodontic Consumables Market Analysis, Industry Size, Share And New Opportunities Till 2024

The Report Orthodontic Consumables Market Analysis by Product (Anchorage Appliances - Buccal Tubes, Miniscrews, Bands; Ligatures - Elastomeric Ligatures, Wire Ligatures; Brackets - Aesthetic Brackets, Self-Ligating Brackets, Metal Brackets, Cosmetic Brackets; Archwires - Beta Titanium Archwire, Nickel Titanium Archwire, Stainless Steel Archwire) by Region (U.S., Canada, UK, Germany, China, India, Brazil, Mexico, South Africa, Middle East), and Segment Forecasts to 2024

The Orthodontic Consumables Market is expected to reach USD 5.4 billion by 2024, according to a new report by Grand View Research, Inc. The orthodontic consumables market constitutes an important part of the dental supplies industry and is expected to witness significant growth in the forecast period. As demand for maintaining a salubrious oral health and dental hygiene is becoming an increasingly important aspect globally, the demand for orthodontic procedures is gaining significant momentum. The market is witnessing notable growth owing to factors such as high prevalence of malocclusion, one of the most prevalent dental conditions worldwide; increasing use of dental services by the aging population; and growing demand for cosmetic dentistry procedures. However, factors such as low access to oral health care in developing countries and the lack of access to oral healthcare facilities in rural areas are anticipated to restrain the growth. Segmentation of the orthodontic consumable market has been provided at the end of this document.

The brackets segment is estimated to lead the market because of its widespread use in fixed orthodontics, which has gained popularity, and this has resulted in tremendous overall growth of this segment. Self-ligating bracket segment is also anticipated to grow at a healthy CAGR in the forecast period because of its increased treatment efficiency.

Another extremely important factor is “evolution.” As food habits are changing, the requirement for large bulky jaws is receding, which has led to smaller jaws in humans, and lack of space for 32 teeth in smaller jaw results in malocclusion. This is indirectly driving the orthodontic consumables market

Access Research Report of Orthodontic Consumables Market @ www.grandviewresearch.com/industry-analysis/orthodontic-consumables-market

Further Key Findings From the Study Suggest:

• North America is estimated to account for the highest share in 2015, followed by Europe. Growth in North America is recognized to be from factors such as an increase in U.S. population, mainly the geriatric segment, significant technological advances in dentistry, and the increasing insurance coverage by third-party providers.
• Self-ligating bracket is expected to command the highest share as it does not require external ligature or elastic to hold the archwire in position. This is expected to fuel growth of the brackets segment, which is anticipated to grow at a healthy CAGR in the forecast period.
• Asia Pacific is expected to witness the fastest growth pertaining to factors such as dense population in the region, an increasing trend of malocclusion, and the gradual advent of dental practice in the region.
• Some major players leading the industry are 3M Unitek; DB Orthodontics; Align Technology, Inc.; G&H Orthodontics; Rocky Mountain Orthodontics; Henry Schein, Inc.; American Orthodontics, Danaher Corporation, and DENTSPLY International.
• Invisalign aligners is an upcoming subsegment in orthodontics. As more and more people are becoming appearance conscious, the demand for these invisible customized aligners is on the rise.

Grand View Research has segmented the orthodontic consumables market on the basis of product and region:

Orthodontic Consumables Product Outlook (Revenue, USD Million, 2013 - 2024)

• Anchorage Appliances
  • Buccal Tubes
  • Miniscrews
  • Bands
• Ligatures
  • Elastomeric Ligatures
  • Wire Ligatures
• Brackets
  • Aesthetic Brackets
  • Self-ligating Brackets
  • Metal Brackets
  • Cosmetic Brackets
• Archwires
  • Beta Titanium Archwire
  • Nickel Titanium Archwire
  • Stainless Steel Archwire

Orthodontic Consumables Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Middle East

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Heart Attack Diagnostics Market to Reach around USD 15.4 Billion by 2024| Key participants Siemens Healthcare GmbH

The Report Heart Attack Diagnostics Market Analysis by Test type (Electrocardiogram, Blood Tests (Troponin, CK-MB), Echocardiogram), by Region (U.S., Canada, UK, Germany, China, India, Brazil, Mexico, South Africa, Middle East), and Segment Forecasts to 2024

The heart attack diagnostics market is expected to reach USD 15.4 billion by 2024, according to a new report by Grand View Research, Inc. The heart attack diagnostics market is anticipated to witness a lucrative growth during the forecast period from2016 to 2024. From 2001 to 2011, age-standardized, heart attack incidence rates have significantly decreased worldwide. However, the overall risk factors and the disease burden remains large, thereby rendering the heart attack diagnostic sectors a profitable growth prospect. This growth is attributed to a majority of factors, such as high prevalence of coronary heart diseases, increased tobacco smoking, and obesity, enhanced adoption of unhealthy diet is resulting in a high cholesterol incidence in individuals, particularly in the rising geriatric population. However, the low Medicare reimbursement provided for the mobile cardiac outpatient telemetry electrocardiogram (ECG) and the progressively declining heart attack incidence rates are expected to hamper the market growth. 

The heart attack diagnostics market has been classified by product into electrocardiogram, which measures the electrical activity of the heart; echocardiogram, a form of ultrasound test that provides images of the heart; blood tests that measure the expression of certain proteins in excess, such as troponin levels, and cardiac enzymes; and other diagnostic products. The ECG segment is expected to witness a significant growth rate in developing countries, owing to the technological advances coupled with increasing applications of ECG. Although, the increasing demand for cost effective, rapid blood tests such as troponin and Creatine Kinase MB Isoenzyme (CK-MB) is likely to acquire major market share in the near future. The key countries landscape included in the report are U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa, and Middle East. The Asia Pacific region is anticipated to be the fastest growing region during the forecast period. On the other hand, North America is estimated to dominate the global heart attack diagnostics market.  

Access Research Report of Heart Attack Diagnostics Market @ www.grandviewresearch.com/industry-analysis/heart-attack-diagnostics-market

Further key findings from the study suggest:

• North America is estimated to dominate the global heart attack diagnostics market. The increasing awareness about heart attacks, its causative and risk factors, and enhanced uptake and acceptance of technologically advanced diagnostics is expected to contribute to the market growth.
• The Asia Pacific region is expected to be the fastest growing region during the forecast period. to The reason being the considerably large burden of heart diseases in certain developing regions, such as in India, where 2.4 million people die annually due to heart diseases. As a result of the soaring incidences of heart diseases, an urgent requirement to undertake awareness measures and incorporate advanced diagnostics is expected to fuel the market growth.
• The troponin blood test type is the largest grossing segment and is expected to capture the largest share in 2015, especially in developing countries including Brazil, China, and India. Its applications as a cardiac monitoring device and its indispensable use as a heart attack diagnostic tool will be a contributing factor supporting the market growth. The industry comprises of several local as well as global players. Some of the major players of this industry include Siemens Healthcare GmbH, Schiller AG, GE Healthcare, and Hitachi Medical Systems. 

Grand View Research has segmented the heart attack diagnostics market on the basis of product and region: 

Heart Attack Diagnostics Test Type Outlook (Revenue, USD Million, 2013 - 2024)

• Electrocardiogram (ECG)
• Blood tests
• Others

Heart Attack Diagnostics Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Durable Medical Equipment Market Expected to Witness a CAGR of 6.1% through 2026

The Report Durable Medical Equipment (DME) Market Size, Share & Trends Analysis Report By Product, By End Use (Hospitals, Nursing Homes), By Region (North America, MEA, APAC, Europe), And Segment Forecasts, 2019 - 2026

The global durable medical equipment (DME) market size is expected to reach USD 271.0 billion by 2026 registering a CAGR of 6.1%, according to a new report by Grand View Research, Inc. The market is primarily driven by rise in chronic diseases, such as kidney failures and cancer. Moreover, technological advancements along with strong reimbursement scenario will boost the DME market further. For instance, in January 2019, WHILL, Inc., a U.S.-based personal electric vehicle, introduced new technology WHILL autonomous drive at the Consumer Electronic Sow held at the Las Vegas. In the past, Medicare has taken steps to bring reimbursement of DME products in line with other payers.

In this direction, in December 2015, the Center for Medicare & Medicare Services (CMS) issued a new rule of prior authorization process for DME, Prosthetics, Orthotics, and Supplies (DMEPOS). The DMEPOS includes the master list of 135 items, which require prior authorization before beneficiary receives an item. In addition, growing geriatric population across the globe is likely to contribute to the industry expansion. People aged 60 years or above are more prone to health issues, such as diabetes, mobility issues, Cardiovascular Diseases (CVDs), and other lifestyle problems. This creates demand for DME products. However, stringent regulatory guidelines in developed economies and lack of skilled professionals may limit the durable medical equipment market growth.

Access Research Report of Durable Medical Equipment Market @ https://www.grandviewresearch.com/industry-analysis/durable-medical-equipment-dme-market

Further key findings from the study suggest:

• Personal mobility devices emerged as the largest segment owing to the launch of technologically advanced products with more comfort and portability
• Nursing homes is anticipated to be the fastest-growing segment over the study period as these facilities offer custodial care like skilled care, such as bathing and dressing
• Europe led the market with the largest share in 2018 and will witness a steady growth in future on account of the presence of major companies in the region
• Asia Pacific is expected to register the highest CAGR from 2019 to 2026 owing to the presence of a large target population base and improving healthcare facilities
• Some of the key companies in the global DME market are Invacare Corporation; ArjoHuntleigh; Stryker Corporation; Hill Rom, Inc.; Drive Medical; GF Health Products, Inc.; Sunrise Medical; Medline Industries, Inc.; and Carex Health Brands, Inc.

Grand View Research has segmented the global Durable Medical Equipment (DME) market on the basis of product, end use, and region:

DME Product Outlook (Revenue, USD Million, 2015 - 2026)

• Personal Mobility Devices
• Bathroom Safety Devices and Medical Furniture
• Monitoring and Therapeutic Devices

DME End Use Outlook (Revenue, USD Million, 2015 - 2026)

• Hospital
• Nursing Homes
• Home Healthcare
• Other

DME Regional Outlook (Revenue, USD Million, 2015 - 2026)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Arthroscopy Market To Make Great Impact In Near Future by 2024

Global arthroscopy market is anticipated to reach USD 6.34 billion by 2024, according to a new report by Grand View Research, Inc. Increasing geriatric population base and rising obesity levels are the major factors driving the growth.

Rising medical tourism, cost efficiency and faster recovery rate are some of the factors resulting in increased adoption. As a result, demand for arthroscopy is increasing, since it’s used in the diagnosis of joint conditions. In addition, constant decline in the price coupled with reimbursement coverage is spurring the adoption of arthroscopy in the treatment of injuries.

Presently, the sector is fragmented in nature with presence of many players competing with each other. The key players are implementing mergers and acquisition strategies to strengthen their position by the expansion of customer base and reduce the number of competing players.

To request a sample copy or view summary of this report, click the link below:http://www.grandviewresearch.com/industry-analysis/arthroscopy-market

Further key findings from the study suggest:

• Arthroscopic implant segment dominated globally and is estimated to remain dominant throughout the forecast period. Increasing adoption of implants for diagnosis is mainly driving the growth of the segment.
• The arthroscopic visualization systems are anticipated to witness strong demand during the forecast period due to their ability to provide clear high definition resolution of internal organs.
• The demand for Fluid Management Systems is going to increase considerably during the forecast period with new products entering the sector especially in emerging countries such as Brazil, Mexico and South Africa.
• The key players have faced challenges due to severe pricing pressures and stringent regulatory guidelines. The existing companies are finding it difficult to garner strong revenues.
• Rising demand for minimally surgeries is also supporting the revenue growth since arthroscopy supports the same.
• China, India, Brazil and South Africa are anticipated to register significant growth over the forecast period owing to rising patient awareness related to arthroscopy, presence of largest pool of geriatric population prone to injuries and the surging prevalence of chronic diseases such as osteoarthritis, bone tumor and rheumatoid arthritis.
• Lenient regulatory approval procedures in Asia Pacific are offering easy entry of the new products in the region.
• Some of the key players operating at the global level include but are not limited to ConMed Corporation, Arthrex Inc, Stryker Corporation, Olympus Corporation, Smith & Nephew plc, DePuy Synthes and Zimmer Biomet.
• North America dominated the global scenario with regional share of over 40.0% in 2015. Technological advancements, such as introduction of advanced visualization systems, primarily led to highest revenue generation in the region. Visualization systems help in minimally invasive surgery by providing 3D image of the joint.
• In addition, favorable reimbursement structure, presence of large target patient population and well defined regulatory framework are few factors that are positively affecting the market.

Grand View Research has segmented the Arthroscopy market on the basis of product, application, and region:

Arthroscopy Market, by Product

• Powered Shave Systems
• Visualization Systems
• Fluid Management Systems
• Ablation Systems
• Arthroscopes
• Arthroscope Implants
• Accessories and Disposables

Arthroscopy Market, by Application

• Hip
• Knee
• Shoulder
• Foot & Ankle
• Hand & Wrist
• Elbow
• Sports Medicines

Arthroscopy Market, by Region

• North America
  • US.Arthroscopy Market, by Product
  • US.Arthroscopy Market, by Application
  • Canada Arthroscopy Market, by Product
  • Arthroscopy Market, by Application
• Europe
  • Germany Arthroscopy Market, by Product
  • UK.Arthroscopy Market, by Product
• Asia Pacific
  • China Arthroscopy Market, by Product
  • Japan Arthroscopy Market, by Product
• Latin America
  • Brazil Arthroscopy Market, By Product
  • Mexico Arthroscopy Market, By Product
  • Rest of Latin America Arthroscopy Market, By Product
• MEA
  • South Africa Arthroscopy Market, By Product
  • Middle East Arthroscopy Market, By Product

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Aesthetic Lasers Market is Estimated To Expand at a CAGR of 15.5% through 2024

The Report Aesthetic Lasers Market Analysis by Application (IPL Laser Treatment, Laser Skin Resurfacing, Noninvasive Tightening, Laser-Assisted Lipoplasty, Laser Hair Removal), and Segment Forecasts to 2024

The global aesthetic lasers market is expected to reach USD 1.8 billion by 2024, according to a new report by Grand View Research, Inc. The demand is expected to upsurge due to aging population, high prevalence of obesity, and wide range of safe and effective treatments. Moreover, growing awareness about the safety and efficacy of lasers coupled with its ease of use is also expected to propel its cosmetic applications.

Advancement of technology has made needle-free procedures possible, thus boosting the rate of adoption of laser treatments. Young population also opts for cosmetic procedures as preventive measures for and to slow down the aging process.

Companies operating in this market are making huge investments in research and development of new products and holding patents. For instance, in 2014, Cutera (provider of energy-based medical Aesthetic technologies) invested USD 10.5 million for pure research purposes and holds 34 patents along with5 patent applications in the pipeline.

Stringent regulations for the cosmetic laser products are projected to ensure increasing efficiency of the devices while treating the skin without any adverse effects. The manufacturers of laser devices have to comply with the Federal Food, Drug, and Cosmetic Act in addition to radiation safety performance standards defined by the Federal Regulations.

In April 2016, Oculus Innovative Sciences, Inc. received the FDA approval for Microcyn-based Lasercyn Gel, intended for post-non-ablative laser therapy procedures management

Access Research Report of Aesthetic Lasers Market @ http://www.grandviewresearch.com/industry-analysis/aesthetic-lasers-market

Further Key Findings from the Study Suggests:

• Hair removal is the fourth most common minimally invasive procedure across the globe with approximately 1 million procedures done in the year 2011.It dominated the application segment in terms of number of procedures owing to the changing beliefs of beauty and lifestyle.
• Conventional hair removal methods are painful and temporary. Thus, using lasers for permanent hair removal proves to be efficient. Also, growing safety assurance results in more people opting for it. Almost 97% people who have undergone the procedure report satisfactory outcomes.
• Laser skin resurfacing segment is expected to grow at a rapid rate over the forecast period. This is attributed to the fact that it reduces the signs of aging and improves skin texture, tone, & laxity. Furthermore, increasing innovation and technological advancements brought in by the market players are expected to propel demand of the segment in the coming years.
• For instance, Sciton JOULE is an expandable platform that offers an unprecedented laser array and light wavelengths via any of its three distinct delivery modes that are broadband light, fiber, and arm, enabling practitioners with the maximum versatility to perform surgical and Aesthetic procedures from a single platform. It is the first OptiPlex platform to accommodate abovementioned three distinct delivery modes.
• Some incredible creative solutions have been prompted with the increasing demand for laser skin resurfacing. In 2010, Solta Medical (fractional resurfacing and noninvasive skin tightening pioneer) announced an FDA clearance of Fraxel restore Dual for treating actinic keratosis.
• North America dominated the market in 2015. It is due to the early acceptance of laser technology and growing awareness about lasers and its efficiency in treating all the skin type.
• The prevalence of medical spas is very high in this region. In 2012, approximately 2,100 med spas were operative in the U.S., generating revenue USD 1.94 billion per year. This number grew to USD 3.6 billion in 2016. Growing emphasis on beauty and attractiveness and its direct impact on success are expected to further increase the market share of the region.
• Some key players are Solta Medical, Inc. (acquired by Valeant Pharmaceuticals); Lumenis; Cynosure, Inc.; STRATA Skin Sciences; Syneron Medical Ltd., Lutronic, Cutera, Viora, Lynton Lasers, and Sciton, Inc.
• The industry is experiencing many mergers and acquisitions between competitors. In December 2014, Valeant Pharmaceuticals International acquired Solta Medical, Inc. in USD 236 million.
• In 2015, Mela Sciences acquired XTRAC and VTRAC laser and lamp systems from PhotoMedex, Inc. in USD 42.5 million. Moreover, the company was renamed to Strata Skin Sciences.

Grand View Research has segmented the global aesthetic lasers market on the basis of application and regions:

Aesthetic Lasers Application Outlook (Revenue, USD Million, 2013 - 2024)

• IPL Laser Treatment
• Laser Skin Resurfacing
• Noninvasive Tightening
• Laser-Assisted Lipoplasty
• Laser Hair Removal

Aesthetic Lasers Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Therapeutic Drug Monitoring Market Poised to Expand at a Robust Pace Over 2024

The global therapeutic drug monitoring market is expected to reach over USD 3.37 billion by 2024, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth.

The employment of continuous therapeutic drug and metabolite monitoring in the early phase of the medication regimen, administered post-organ transplantation, forms a major application in the areas of critical care medicine and organ transplantation, which is expected to propel the growth of the therapeutic drug monitoring market over the forecast period. In addition, the imposing burden of diseases, such as epilepsy and cancer, the rising government initiatives, and the presence of high-unmet needs are some of the crucial determinants expected to further favor the emergence of this market.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/therapeutic-drug-monitoring-market

Further key findings from the study suggest:

• The consumables segment covered over 65% of the market share in 2015 as a consequence of the extensive requirement of the consumables in the research laboratories and due to the repeat purchase of the kits and reagents.
• The immunoassay segment held the largest market share in 2015. The presence of several commercially available immunoassays combined with their associated benefits including the cost effectiveness and easy-to-handle nature of the products are the key drivers for the growth of this segment.
• The proteomics category is expected to be the fastest growing technology segment due to the advent of various proteomic technologies, such as isotope-coded affinity tags, next generation sequencing, and protein microarray platforms that enable rapid mining of the proteome.
• The hospital is the largest end-use segment with a share of over 60% in 2015. In larger hospitals, various underlying technologies are employed to perform immunoassays; these comprise chemiluminescence, nephelometry, colorimetry, and fluorescence, which are available for the testing of a wide ranging drug panel.
• The drug monitoring for the immunosuppressants is one of the fastest growing application segments owing to the introduction of novel TDM point-of-care testing devices for the evaluation of the concentration of administered immunosuppressants and the complementary metabolites, in order to achieve a prominent therapeutic effect while preventing drug toxicity events in patients that have undergone transplantations.
• In 2015, North America was the highest revenue generating region with revenue generated over USD 900 million. The rising number of R&D activities coupled with the high awareness about personalized therapy is the major determining factor for the large share captured by the North America region.
• Few of the leading market players are Roche Diagnostics, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMérieux, Inc., and Alere, Inc. The persistent R&D efforts are being undertaken along with numerous other strategic endeavors being adopted by the market players with the objective of enhancing the present drug monitoring practices and to develop novel technologies.

Grand View Research has segmented the therapeutic drug monitoring market on the basis of product, technology, application, end-use, and region:

Therapeutic Drug Monitoring Market, Product Outlook, by Revenue (USD Million, 2013 - 2024)

• Consumables
• Equipment
• Others

Therapeutic Drug Monitoring Market, Technology Outlook, by Revenue (USD Million, 2013 - 2024)

• Immunoassays
• Proteomic technologies
• Others

Therapeutic Drug Monitoring Market Drug, Class Outlook, by Revenue (USD Million, 2013 - 2024)

• Anti-epileptics
• Antibiotics
• Immunosuppressants
• Psychoactive drugs
• Antiarrhythmic drugs
• Others

Therapeutic Drug Monitoring Market, End-use Outlook, by Revenue (USD Million, 2013 - 2024)

• Hospital labs
• Private labs
• Others

Therapeutic Drug Monitoring Market, Regional Outlook, by Revenue (USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Antibiotics Market Strong Application and Emerging Trends also Scope by 2026| Top Industry Leaders Sanofi, Novartis AG, Bayer AG

The global antibiotics market size is expected to reach USD 62.06 billion by 2026 expanding at a CAGR of 4.0%, according to a new report by Grand View Research, Inc. Rising prevalence of infectious diseases, especially in developing regions like Asia Pacific and Middle East, is anticipated to contribute to the market growth. More than 15.0% of the deaths in children below the age of five years, are estimated to be due to pneumonia and according to the statistics provided by the WHO about 9.2 million deaths were recorded in 2015. Similar to tuberculosis, the disease is highly prevalent in the South Asian and Sub-Saharan regions. Currently, the required antibiotic treatment is available only to one-third of the infected population, thereby increasing the disease burden.

Government reforms specific to antibiotics, such as the Generating Antibiotics Incentives Now (GAIN) Act in U.S., are projected to help boost the market growth over the forecast period. This is further expected to facilitate development of advanced drugs. According to an article published by the Pew Charitable Trusts, nearly 30% of the outpatient oral antibiotics prescriptions are unnecessary and majority of these are prescribed for disease conditions, such as non-bacterial infections and acute respiratory conditions, against which antibiotics are not significantly effective. Such indiscriminate use of antibiotics is anticipated to increase the risk of difficult-to-treat antibiotic-resistant infections, thereby increasing the economic burden.

Access Research Report of Antibiotics Market@ https://www.grandviewresearch.com/industry-analysis/antibiotic-market

Further key findings from the study suggest:

• RNA and folic acid synthesis inhibitors are anticipated to witness healthy CAGRs over the forecast period
• Development of several antiviral drugs, which inhibit transcription and reverse transcription process are anticipated to support this growth
• Asia Pacific is anticipated to witness the highest CAGR over the forecast period on account of large population base, prevalence of infectious diseases, regulation reforms, and wide usage of generic medicine
• Latin America, especially Brazil, is also projected to exhibit remunerative growth due to strong growth in pharmaceutical sector
• Outbreak of certain viruses, such as Ebola, in African region contributed to the region’s growth
• Some of the key companies in the market are Pfizer, Inc; Janssen Pharmaceuticals; Abbott laboratories; GlaxoSmithKline plc; Sanofi S.A.; Novartis AG; Bayer AG; Bristol Myers Squibb Company; Eli Lilly & Company, and Astellas Pharma, Inc.

Grand View Research has segmented the global antibiotics market on the basis of action mechanism, drug class, and region:

Antibiotics Action Mechanism Outlook (Revenue, USD Million, 2015 - 2026)

• Cell Wall Synthesis Inhibitors
• Protein Synthesis Inhibitors
• DNA Synthesis Inhibitors
• RNA Synthesis Inhibitors
• Mycolic Acid Inhibitors

Antibiotics Drug Class Outlook (Revenue, USD Million, 2015 - 2026)

• Cephalosporin
• Penicillin
• Fluoroquinolone
• Macrolides
• Carbapenems
• Aminoglycosides
• Sulfonamide
• Other

Antibiotics Regional Outlook (Revenue, USD Million, 2015 - 2026)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Geriatric Medicine Market to Register Stable Expansion by – 2024|Top Industry Players Sanofi S.A., Bristol-Myers Squibb

The global geriatric medicine market is expected to reach over USD 1,017 billion by 2024 according to a new report by Grand View Research Inc. Increase in the global geriatric population is one of the major challenges for the healthcare industry and the governments across the globe, however, it has proven to be a boon for the geriatric medicine market. 

The high market growth is anticipated on account of the rising prevalence of various target diseases in the geriatric population, the demographic shift, the upward trend in lifestyle-related risk factors, and the significantly improved access to affordable healthcare as well as medicine across the developing and emerging economies. 

The rising prevalence of the Alzheimer’s disease in the geriatric population is expected to serve as a high impact rendering driver for the geriatric medicine market over the forecast period. In 2015, as per the estimates published by the Alzheimer’s disease International, nearly 47 million people have dementia and this number is expected to double after every 20 years. Furthermore, as per the estimates published by The Alzheimer's Association, in the U.S., out of the 5.4 million Americans living with the disease, nearly 5.2 million or 96.3% are aged 65 and above.

In order to mitigate the concerns arising due to the unfavorable shift in the demographic variables such as age, lifestyle patterns, economic development, coupled with the upward shift in the disease trends associated with the geriatric population, the developed regions have consistently improved their healthcare practices by allocating high amount of resources towards the healthcare and social development sectors.

For instance, the U.S., Germany, the UK, and Japan allocate 17.1%, 11.30%,9.10%,10.20%, of their GDP respectively towards healthcare expenditure and majority of these resources are channelized towards developing new drugs, new software, and building technology platforms for hospitals and home health services.

Access Research Report of Geriatric Medicine Market@ www.grandviewresearch.com/industry-analysis/geriatric-medicine-market

Further key findings from the study suggest:

• In 2015, analgesic medicine accounted for the highest revenue of nearly USD123 billion. The key factors attributed to include the rising prevalence of various types of pains associated with aging. These pains can be categorized as general body pain, post-surgical pain, muscle pain, acute or chronic joint pain, neuropathic pain, and others.
• In 2015, North America dominated the geriatric medicine market with a revenue share of over 37% owing to the presence of well-developed social and healthcare sectors, the availability of the latest medicine, and insurance coverage coupled with the presence of a large number of people aged above 60 years.
• Asia Pacific region is anticipated to exhibit the maximum growth rate at a CAGR of over 7% from the year 2016 to 2024. In comparison with the developed regions, the economic burden of the target diseases, the access to healthcare, health insurance and the percentage of public and private healthcare expenditures vary significantly in the Asia Pacific countries.
• The countries such as China and India are expected to witness a significant rise in the elderly population base and this factor in turn is expected to create an upward trend in the geriatric medicine market over the forecast period.
• The market dynamics indicate the presence of strong competition amongst the key players such as Eli Lilly and Company, AstraZeneca plc, Boehringer Ingelheim GmbH, Abbott Laboratories., Sanofi S.A., Bristol-Myers Squibb, Merck & Company Inc., Novartis AG, Pfizer, Inc., and GlaxoSmithKline Plc.

Grand View Research has segmented the geriatric medicine market by therapeutic category, therapeutic condition, and region:

Geriatric Medicine Market by therapeutic category (USD Billion, 2016 - 2024)

• Analgesics
• Antihypertensives
• Statins
• Antidiabetics
• Proton Pump Inhibitor
• Anticoagulant
• Antipsychotics
• Antidepressants

Geriatric Medicine Market by therapeutic condition, by Revenue (USD Billion,2016 - 2024)

• Cardiovascular diseases
• Arthritis
• Neurological Disorders
• Cancer
• Osteoporosis
• Respiratory

Geriatric Medicine Market Regional Outlook, by Revenue (USD Billion, 2016 - 2024)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Alopecia Market Set to Surge Significantly During the Forecast Period

The global alopecia market size is poised to reach USD 5.3 billion by 2027 and is anticipated to register a CAGR of 9.5% over the forecast period, according to a new report published by Grand View Research, Inc. Increasing prevalence of diseases across the globe, technological progress, and growth in per-capita expenditures toward healthcare are some of the factors expected to drive the market growth in the coming years.

There has been a marked increase in the overall disease prevalence due to changing lifestyle patterns such as surging consumption of tobacco and alcohol, unhealthy and inconsistent food habits, intense stress levels, and expanding geriatric population, thus contributing to the market growth. In addition, rising incidences of chronic diseases such as rheumatoid arthritis, cancer, and Polycystic Ovary Syndrome (PCOS) are anticipated to fuel the market growth.

The National Alopecia Areata Foundation stated that 147 million people are suffering from alopecia areata worldwide. Expanding consumer awareness towards this disease and possible treatments options are expected to augment the alopecia market growth. For instance, National Alopecia Areata Foundation’s Treatment Development Program (TDP) has accelerated the research work pertaining to this condition.

Rogaine and Propecia remain the only FDA-approved products in this market. Patent expiration of branded drugs has expanded the generic penetration in this space. However, impending launch of multiple promising pipeline products, such as Xeljanz (tofacitinib), Jakafi (ruxolitinib), Breezula (clascoterone), SM04554, and Lumigan (Bimatoprost) is likely to inflate market growth in the near future.

Reimbursement for alopecia treatment continues to be a major challenge in this market. Most treatment modalities for this disorder are considered cosmetic and not medically essential, thus mostly remain uncovered under insurance schemes. Frequent doctor visits, coinsurance for procedures, and prescription drug copays are some of the major out-of-pocket costs for this disease treatment.

Access Research Report of Alopecia Market @ http://www.grandviewresearch.com/industry-analysis/alopecia-market

Further key findings from the study suggest:

• The alopecia areata disease type segment contributed for over 30% of the revenue share in 2019
• The androgenetic alopecia disease type segment is positioned to demonstrate a growth rate of over 10% over the forecast period
• The homecare settings end-use segment is projected to be broadening penetration of laser treatment and rise in regulatory sanctions of home-use products
• Asia Pacific is anticipated to witness the fastest growth owing to large population base and rising consumer awareness toward available treatment options
• Economic betterment and increased per capita healthcare spending, in developing countries such as India, China, and Singapore are expected to boost the regional market
• Lack of stringent reimbursement policies is a major factor restraining the market growth since the treatment for this disorder is not considered medically essential
• Some of the key companies in the market of the key companies in the market are Johnson and Johnson Services, Inc.; Sun Pharmaceutical Industries Ltd.; Cipla Inc.; Lexington International LLC; Merck & Co., Inc.; Cirrus Hair Centers; and Transitions Hair Pty Ltd.

Grand View Research has segmented the global alopecia market on the basis of disease type, end use, sales channel, gender, and region:

Alopecia Disease Type Outlook (Revenue, USD Million, 2015 - 2027)

• Alopecia Areata
• Cicatricial Alopecia
• Traction Alopecia
• Alopecia Totalis
• Alopecia Universalis
• Androgenetic Alopecia
• Others

Alopecia End-use Outlook (Revenue, USD Million, 2015 - 2027)

• Homecare Setting
• Dermatology Clinics

Alopecia Sales Channel Outlook (Revenue, USD Million, 2015 - 2027)

• Prescriptions
• OTC

Alopecia Gender Outlook (Revenue, USD Million, 2015 - 2027)

• Male
• Female

Alopecia Regional Outlook (Revenue, USD Million, 2015 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
  • Sweden
  • Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Taiwan
  • Vietnam
  • Thailand
  • Malaysia
  • Singapore
  • Indonesia
  • Philippines
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Egypt
  • Iran
  • Israel

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.